©The Author(s) 2025.
World J Exp Med. Dec 20, 2025; 15(4): 111043
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.111043
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.111043
Table 2 Quality assessment for randomized controlled trials using the Cochrane risk of bias tool
| Ref. | Random sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting | Overall risk |
| Sakaguchi and Watari[3] | Low | Low | High | Low | Low | Low | Moderate |
| Hess et al[9] | Low | Low | Low | Low | Low | Low | Low |
| Subherwal et al[12] | High | High | High | Moderate | Low | Low | High |
| Gibbons et al[13] | Low | Moderate | Moderate | Low | High | Low | Moderate |
| Torrens Cid et al[5] | Low | Low | Low | Low | Low | Low | Low |
| Becker et al[1] | High | Moderate | High | Moderate | Low | Low | High |
| Magro et al[8] | Low | Low | Low | Low | Low | Low | Low |
| Soor et al[7] | Moderate | High | Moderate | Low | Low | Low | Moderate |
- Citation: Kumari M, Kumar N, Meghwar R, Rai R, Rahul F, Hassan MA, Kumar K, Kumar H, Chaudhary MHN, Zahid K, Alam F, Jawed I, Kumar D, Jabeen S, Qadir U, Asim R. Molecular insights from skin biopsies: Deciphering microvascular pathology in peripheral vascular diseases. World J Exp Med 2025; 15(4): 111043
- URL: https://www.wjgnet.com/2220-315x/full/v15/i4/111043.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i4.111043